Ukko

Ukko is a biotech company in Boston, United States, founded in 2016. It has raised $85.0M across 2 rounds, most recently a $45.0M Series C in January 2026.

On a mission to solve food allergies and sensitivities

Employees
11–50
Founded
2016
Business Model
B2B
Website
ukko.us
Total Funding
$85.0M
Last Round
$45.0M Series CJan 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 10 investors for this company. The full record is or through the API.

About

Ukko uses its computational protein design platform to develop immuno-therapeutics for life-threatening food allergies. The company designs new versions of allergens that do not trigger an allergic response but still re-educate the immune system to tolerate the allergen, creating a new treatment approach. Ukko's goal is to revolutionize allergy treatment and improve the lives of the millions of people affected by food allergies and sensitivities.

Summary

It lists 11–50 employees. It has raised $85.0M in total across 2 rounds, most recently a $45.0M Series C round in Jan 2026. Investors include Leaps by Bayer, Israel Biotech Fund and Khosla Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CJan 2026
$45.0M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ukko on Indexed.vc
<a href="https://indexed.vc/companies/ukko"><img src="https://indexed.vc/api/badge/company/ukko" alt="Ukko on Indexed.vc" width="260" height="76" /></a>